Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients

COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) in combination with Avifavir(®) or Hydroxychloroquine (HCQ) drugs, which are recommended b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivashchenko, Andrey A., Azarova, Valeria N., Egorova, Alina N., Karapetian, Ruben N., Kravchenko, Dmitry V., Krivonos, Natalia V., Loginov, Vladimir G., Poyarkov, Stanislav V., Merkulova, Elena A., Rosinkova, Olga S., Savchuk, Nikolay P., Topr, Mikhail A., Simakina, Elena N., Yakubova, Elena V., Ivachtchenko, Alexandre V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310315/
https://www.ncbi.nlm.nih.gov/pubmed/34199134
http://dx.doi.org/10.3390/v13071253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310315/
https://www.ncbi.nlm.nih.gov/pubmed/34199134
http://dx.doi.org/10.3390/v13071253

Ejemplares similares